WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H130339
CAS#: 5394-18-3
Description: N-(4-Bromobutyl)phthalimide is key in the synthesis of imidazo[4,5-b]pyridine derivatives and calix[4]arene and thiacalix[4]arene-based oxamate ligands.
Hodoodo Cat#: H130339
Name: N-(4-Bromobutyl)phthalimide
CAS#: 5394-18-3
Chemical Formula: C12H12BrNO2
Exact Mass: 281.01
Molecular Weight: 282.137
Elemental Analysis: C, 51.09; H, 4.29; Br, 28.32; N, 4.96; O, 11.34
Synonym: N-(4-Bromobutyl)phthalimide; 1-Phthalimido-4-bromobutane; 2-(4-Bromobutyl)-2,3-dihydro-1H-isoindole-1,3-dione; 2-(4-Bromobutyl)phthalimide; 4-Bromobutylphthalimide
IUPAC/Chemical Name: 2-(4-bromobutyl)isoindoline-1,3-dione
InChi Key: UXFWTIGUWHJKDD-UHFFFAOYSA-N
InChi Code: InChI=1S/C12H12BrNO2/c13-7-3-4-8-14-11(15)9-5-1-2-6-10(9)12(14)16/h1-2,5-6H,3-4,7-8H2
SMILES Code: O=C1N(CCCCBr)C(C2=C1C=CC=C2)=O
Appearance: To be determined
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 282.14 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1. Aherne GW, Piall EM, Marks V. The radioimmunoassay of tricyclic antidepressants. Br J Clin Pharmacol. 1976 Aug;3(4):561-5. doi: 10.1111/j.1365-2125.1976.tb04875.x. PMID: 22216494; PMCID: PMC1428902.
2. Kumar P, Dubey KK, Singh RK, Misra K. A novel strategy for O6-protection of guanosine. Nucleic Acids Symp Ser. 1995;(34):51-2. PMID: 8841547.